Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia

Citation

Hardy, A, Palma-Barqueros, V, Watson, S et al 2018, 'Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia', Thrombosis and Haemostasis, vol. 118, no. 6, pp. 1009-1020pp.

Year

2018

Field of Research

  • Receptors And Membrane Biology

Updated:  27 September 2020 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers